Global and United States Anti-Glaucoma Drug Market Report & Forecast 2023-2028

Report ID: 1765126 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Anti-Glaucoma Drug Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Anti-Glaucoma Drug Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Anti-Glaucoma Drug Market Size for the Year 2017-2028
        1.2.2 Global Anti-Glaucoma Drug Market Size for the Year 2017-2028
    1.3 Anti-Glaucoma Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Anti-Glaucoma Drug in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Anti-Glaucoma Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Anti-Glaucoma Drug Market Dynamics
        1.4.1 Anti-Glaucoma Drug Industry Trends
        1.4.2 Anti-Glaucoma Drug Market Drivers
        1.4.3 Anti-Glaucoma Drug Market Challenges
        1.4.4 Anti-Glaucoma Drug Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Anti-Glaucoma Drug by Type
    2.1 Anti-Glaucoma Drug Market Segment by Type
        2.1.1 Miosis Drugs
        2.1.2 Beta-Blocker
        2.1.3 Adrenergic Agonists
        2.1.4 Carbonic Anhydrase Inhibitor
        2.1.5 Prostaglandin Derivative Agent
        2.1.6 Penetrates
    2.2 Global Anti-Glaucoma Drug Market Size by Type (2017, 2022 & 2028)
    2.3 Global Anti-Glaucoma Drug Market Size by Type (2017-2028)
    2.4 United States Anti-Glaucoma Drug Market Size by Type (2017, 2022 & 2028)
    2.5 United States Anti-Glaucoma Drug Market Size by Type (2017-2028)
3 Anti-Glaucoma Drug by Application
    3.1 Anti-Glaucoma Drug Market Segment by Application
        3.1.1 Hospital Pharmacy
        3.1.2 Drugstore
        3.1.3 Online Sales
    3.2 Global Anti-Glaucoma Drug Market Size by Application (2017, 2022 & 2028)
    3.3 Global Anti-Glaucoma Drug Market Size by Application (2017-2028)
    3.4 United States Anti-Glaucoma Drug Market Size by Application (2017, 2022 & 2028)
    3.5 United States Anti-Glaucoma Drug Market Size by Application (2017-2028)
4 Global Anti-Glaucoma Drug Competitor Landscape by Company
    4.1 Global Anti-Glaucoma Drug Market Size by Company
        4.1.1 Top Global Anti-Glaucoma Drug Companies Ranked by Revenue (2021)
        4.1.2 Global Anti-Glaucoma Drug Revenue by Player (2017-2022)
    4.2 Global Anti-Glaucoma Drug Concentration Ratio (CR)
        4.2.1 Anti-Glaucoma Drug Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Anti-Glaucoma Drug in 2021
        4.2.3 Global Anti-Glaucoma Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Anti-Glaucoma Drug Headquarters, Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Anti-Glaucoma Drug Headquarters and Area Served
        4.3.2 Global Anti-Glaucoma Drug Companies Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Anti-Glaucoma Drug Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Anti-Glaucoma Drug Market Size by Company
        4.5.1 Top Anti-Glaucoma Drug Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Anti-Glaucoma Drug Revenue by Players (2020, 2021 & 2022)
5 Global Anti-Glaucoma Drug Market Size by Region
    5.1 Global Anti-Glaucoma Drug Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Anti-Glaucoma Drug Market Size by Region (2017-2028)
        5.2.1 Global Anti-Glaucoma Drug Market Size by Region: 2017-2022
        5.2.2 Global Anti-Glaucoma Drug Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Anti-Glaucoma Drug Market Size YoY Growth 2017-2028
        6.1.2 North America Anti-Glaucoma Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Anti-Glaucoma Drug Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Anti-Glaucoma Drug Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Anti-Glaucoma Drug Market Size YoY Growth 2017-2028
        6.3.2 Europe Anti-Glaucoma Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Anti-Glaucoma Drug Market Size YoY Growth 2017-2028
        6.4.2 Latin America Anti-Glaucoma Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Anti-Glaucoma Drug Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Anti-Glaucoma Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Company Details
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Anti-Glaucoma Drug Introduction
        7.1.4 Pfizer Revenue in Anti-Glaucoma Drug Business (2017-2022)
        7.1.5 Pfizer Recent Development
    7.2 Merck
        7.2.1 Merck Company Details
        7.2.2 Merck Business Overview
        7.2.3 Merck Anti-Glaucoma Drug Introduction
        7.2.4 Merck Revenue in Anti-Glaucoma Drug Business (2017-2022)
        7.2.5 Merck Recent Development
    7.3 Allergan
        7.3.1 Allergan Company Details
        7.3.2 Allergan Business Overview
        7.3.3 Allergan Anti-Glaucoma Drug Introduction
        7.3.4 Allergan Revenue in Anti-Glaucoma Drug Business (2017-2022)
        7.3.5 Allergan Recent Development
    7.4 Santen
        7.4.1 Santen Company Details
        7.4.2 Santen Business Overview
        7.4.3 Santen Anti-Glaucoma Drug Introduction
        7.4.4 Santen Revenue in Anti-Glaucoma Drug Business (2017-2022)
        7.4.5 Santen Recent Development
    7.5 Alcon
        7.5.1 Alcon Company Details
        7.5.2 Alcon Business Overview
        7.5.3 Alcon Anti-Glaucoma Drug Introduction
        7.5.4 Alcon Revenue in Anti-Glaucoma Drug Business (2017-2022)
        7.5.5 Alcon Recent Development
    7.6 Teva Pharmaceuticals
        7.6.1 Teva Pharmaceuticals Company Details
        7.6.2 Teva Pharmaceuticals Business Overview
        7.6.3 Teva Pharmaceuticals Anti-Glaucoma Drug Introduction
        7.6.4 Teva Pharmaceuticals Revenue in Anti-Glaucoma Drug Business (2017-2022)
        7.6.5 Teva Pharmaceuticals Recent Development
    7.7 Fera Pharmaceuticals
        7.7.1 Fera Pharmaceuticals Company Details
        7.7.2 Fera Pharmaceuticals Business Overview
        7.7.3 Fera Pharmaceuticals Anti-Glaucoma Drug Introduction
        7.7.4 Fera Pharmaceuticals Revenue in Anti-Glaucoma Drug Business (2017-2022)
        7.7.5 Fera Pharmaceuticals Recent Development
    7.8 Bausch & Lomb, Inc.
        7.8.1 Bausch & Lomb, Inc. Company Details
        7.8.2 Bausch & Lomb, Inc. Business Overview
        7.8.3 Bausch & Lomb, Inc. Anti-Glaucoma Drug Introduction
        7.8.4 Bausch & Lomb, Inc. Revenue in Anti-Glaucoma Drug Business (2017-2022)
        7.8.5 Bausch & Lomb, Inc. Recent Development
    7.9 Akorn, Inc.
        7.9.1 Akorn, Inc. Company Details
        7.9.2 Akorn, Inc. Business Overview
        7.9.3 Akorn, Inc. Anti-Glaucoma Drug Introduction
        7.9.4 Akorn, Inc. Revenue in Anti-Glaucoma Drug Business (2017-2022)
        7.9.5 Akorn, Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Anti-Glaucoma Drug Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Anti-Glaucoma Drug Market Trends
    Table 3. Anti-Glaucoma Drug Market Drivers
    Table 4. Anti-Glaucoma Drug Market Challenges
    Table 5. Anti-Glaucoma Drug Market Restraints
    Table 6. Global Anti-Glaucoma Drug Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anti-Glaucoma Drug Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anti-Glaucoma Drug Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anti-Glaucoma Drug Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anti-Glaucoma Drug Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anti-Glaucoma Drug Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Anti-Glaucoma Drug Revenue Share by Player, 2017-2022
    Table 13. Global Anti-Glaucoma Drug Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Anti-Glaucoma Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Glaucoma Drug as of 2021)
    Table 15. Top Players of Anti-Glaucoma Drug in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Anti-Glaucoma Drug Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Anti-Glaucoma Drug Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Anti-Glaucoma Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Anti-Glaucoma Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Anti-Glaucoma Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Anti-Glaucoma Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Anti-Glaucoma Drug Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Anti-Glaucoma Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Anti-Glaucoma Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Anti-Glaucoma Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Anti-Glaucoma Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Anti-Glaucoma Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Anti-Glaucoma Drug Product
    Table 33. Pfizer Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. Merck Company Details
    Table 36. Merck Business Overview
    Table 37. Merck Anti-Glaucoma Drug Product
    Table 38. Merck Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million)
    Table 39. Merck Recent Development
    Table 40. Allergan Company Details
    Table 41. Allergan Business Overview
    Table 42. Allergan Anti-Glaucoma Drug Product
    Table 43. Allergan Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million)
    Table 44. Allergan Recent Development
    Table 45. Santen Company Details
    Table 46. Santen Business Overview
    Table 47. Santen Anti-Glaucoma Drug Product
    Table 48. Santen Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million)
    Table 49. Santen Recent Development
    Table 50. Alcon Company Details
    Table 51. Alcon Business Overview
    Table 52. Alcon Anti-Glaucoma Drug Product
    Table 53. Alcon Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million)
    Table 54. Alcon Recent Development
    Table 55. Teva Pharmaceuticals Company Details
    Table 56. Teva Pharmaceuticals Business Overview
    Table 57. Teva Pharmaceuticals Anti-Glaucoma Drug Product
    Table 58. Teva Pharmaceuticals Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million)
    Table 59. Teva Pharmaceuticals Recent Development
    Table 60. Fera Pharmaceuticals Company Details
    Table 61. Fera Pharmaceuticals Business Overview
    Table 62. Fera Pharmaceuticals Anti-Glaucoma Drug Product
    Table 63. Fera Pharmaceuticals Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million)
    Table 64. Fera Pharmaceuticals Recent Development
    Table 65. Bausch & Lomb, Inc. Company Details
    Table 66. Bausch & Lomb, Inc. Business Overview
    Table 67. Bausch & Lomb, Inc. Anti-Glaucoma Drug Product
    Table 68. Bausch & Lomb, Inc. Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million)
    Table 69. Bausch & Lomb, Inc. Recent Development
    Table 70. Akorn, Inc. Company Details
    Table 71. Akorn, Inc. Business Overview
    Table 72. Akorn, Inc. Anti-Glaucoma Drug Product
    Table 73. Akorn, Inc. Revenue in Anti-Glaucoma Drug Business (2017-2022) & (US$ Million)
    Table 74. Akorn, Inc. Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Glaucoma Drug Product Picture
    Figure 2. Global Anti-Glaucoma Drug Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anti-Glaucoma Drug Market Size 2017-2028 (US$ Million)
    Figure 4. United States Anti-Glaucoma Drug Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Anti-Glaucoma Drug Market Size 2017-2028 (US$ Million)
    Figure 6. United States Anti-Glaucoma Drug Market Share in Global 2017-2028
    Figure 7. Anti-Glaucoma Drug Report Years Considered
    Figure 8. Product Picture of Miosis Drugs
    Figure 9. Product Picture of Beta-Blocker
    Figure 10. Product Picture of Adrenergic Agonists
    Figure 11. Product Picture of Carbonic Anhydrase Inhibitor
    Figure 12. Product Picture of Prostaglandin Derivative Agent
    Figure 13. Product Picture of Penetrates
    Figure 14. Global Anti-Glaucoma Drug Market Share by Type in 2022 & 2028
    Figure 15. Global Anti-Glaucoma Drug Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Anti-Glaucoma Drug Market Share by Type (2017-2028)
    Figure 17. United States Anti-Glaucoma Drug Market Share by Type in 2022 & 2028
    Figure 18. United States Anti-Glaucoma Drug Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Anti-Glaucoma Drug Market Share by Type (2017-2028)
    Figure 20. Product Picture of Hospital Pharmacy
    Figure 21. Product Picture of Drugstore
    Figure 22. Product Picture of Online Sales
    Figure 23. Global Anti-Glaucoma Drug Market Share by Application in 2022 & 2028
    Figure 24. Global Anti-Glaucoma Drug Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Anti-Glaucoma Drug Market Share by Application (2017-2028)
    Figure 26. United States Anti-Glaucoma Drug Market Share by Application in 2022 & 2028
    Figure 27. United States Anti-Glaucoma Drug Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Anti-Glaucoma Drug Market Share by Application (2017-2028)
    Figure 29. North America Anti-Glaucoma Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Anti-Glaucoma Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Anti-Glaucoma Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Anti-Glaucoma Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Anti-Glaucoma Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E Anti-Glaucoma Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Pfizer Revenue Growth Rate in Anti-Glaucoma Drug Business (2017-2022)
    Figure 58. Merck Revenue Growth Rate in Anti-Glaucoma Drug Business (2017-2022)
    Figure 59. Allergan Revenue Growth Rate in Anti-Glaucoma Drug Business (2017-2022)
    Figure 60. Santen Revenue Growth Rate in Anti-Glaucoma Drug Business (2017-2022)
    Figure 61. Alcon Revenue Growth Rate in Anti-Glaucoma Drug Business (2017-2022)
    Figure 62. Teva Pharmaceuticals Revenue Growth Rate in Anti-Glaucoma Drug Business (2017-2022)
    Figure 63. Fera Pharmaceuticals Revenue Growth Rate in Anti-Glaucoma Drug Business (2017-2022)
    Figure 64. Bausch & Lomb, Inc. Revenue Growth Rate in Anti-Glaucoma Drug Business (2017-2022)
    Figure 65. Akorn, Inc. Revenue Growth Rate in Anti-Glaucoma Drug Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Merck
Allergan
Santen
Alcon
Teva Pharmaceuticals
Fera Pharmaceuticals
Bausch & Lomb, Inc.
Akorn, Inc.
Frequently Asked Questions
Anti-Glaucoma Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-Glaucoma Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-Glaucoma Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports